Vitamin B5,Pantothenic Acid / Risk Cancer Research Results

VitB5, Vitamin B5,Pantothenic Acid: Click to Expand ⟱

Features:

Vitamin B5 (Pantothenic Acid) plays several roles in the brain, and emerging evidence suggests it may be relevant to Alzheimer’s disease (AD)—particularly through its involvement in acetylcholine synthesis, energy metabolism, and oxidative stress response.
-Precursor to Coenzyme A (CoA)
-CoA is essential for mitochondrial energy production, lipid metabolism, and acetylcholine synthesis.
-CoA + choline → acetylcholine. ACh levels are reduced in AD; B5 deficiency may worsen this.
-Pantothenic acid is indirectly involved in cysteamine production, via CoA turnover.
-cysteamine can cross the BBB and increases BDNF levels.
-Pantothenic Acid (D-calcium pantothenate) Most common, stable, and well-absorbed form, water soluable
-Heat(cooking) may degrade the B5.
-Adequate Intake is 5mg/day. Target 10-15mg/day (300–900 mg/day under supervision)

-must be replenished daily; no long-term storage

Beef liver (3 oz cooked)   ~8.3 mg
Sunflower seeds (1 oz)	   ~2.0 mg
Chicken (3 oz cooked)	   ~1.0 mg
Salmon (3 oz cooked)	   ~1.6 mg
Avocado (1 whole)	   ~1.0–2.0 mg
Egg (1 large)	           ~0.7 mg
Mushrooms (½ cup cooked)   ~1.5 mg

Vitamin B5 (Pantothenic Acid; PA) = water-soluble B-vitamin; dietary sources include meats, whole grains, legumes; precursor to Coenzyme A (CoA) and acyl-carrier protein (ACP).
Primary mechanisms (conceptual rank):
1) CoA synthesis → central to acetyl-CoA flux (TCA cycle, fatty acid synthesis/β-oxidation, cholesterol/steroid synthesis).
2) Epigenetic substrate control → acetyl-CoA availability influences histone acetylation (H3/H4 acetyl marks).
3) Redox-metabolic integration → CoA-dependent NADH/FADH2 generation (indirect ROS modulation via mitochondrial flux).
4) Rapidly proliferating cell support → high CoA demand in lipogenic tumors (metabolic permissive role rather than direct cytotoxicity).
PK / bioavailability: efficiently absorbed in small intestine via SMVT transporter; plasma levels tightly regulated; excess rapidly excreted; no meaningful tissue “supra-physiologic” accumulation from oral dosing.
In-vitro vs systemic exposure: most cancer cell studies manipulate CoA enzymes (e.g., PANK) rather than achievable oral PA concentrations; in-vitro millimolar exposures exceed physiological serum levels.
Clinical evidence status: no RCT evidence supporting anti-cancer efficacy; primarily nutritional sufficiency role; deficiency rare.

Vitamin B5 (Pantothenic Acid) — Cancer-Relevant Pathways

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	CoA synthesis / Acetyl-CoA pool	↑ (supports proliferation)	↑ (physiologic support)	G	Metabolic substrate enabling	Central biochemical role; tumors with high lipogenesis depend on robust CoA flux; PA is permissive, not selectively cytotoxic.
2	TCA cycle / mitochondrial flux	↑ (fueling)	↑	R→G	Energy metabolism support	Indirectly affects NADH/FADH2 production; not a direct ETC inhibitor or activator.
3	Fatty acid synthesis (FASN axis)	↑ (lipogenic tumors)	↑	G	Lipid biosynthesis substrate	Acetyl-CoA → malonyl-CoA pathway; high relevance in breast, prostate, liver cancers with lipogenic phenotype.
4	Histone acetylation (epigenetic)	↑ (context-dependent)	↑	G	Chromatin acetylation permissive	Acetyl-CoA availability influences H3/H4 acetyl marks; effect magnitude depends on metabolic state rather than supplementation alone.
5	ROS tone	↔ (indirect)	↔	R	Secondary to mitochondrial flux	No primary antioxidant property; ROS shifts occur via altered metabolic throughput.
6	NRF2 axis	↔	↔	G	No direct activation	Not a canonical NRF2 modulator; any effect is secondary to metabolic stress context.
7	Ca²⁺ signaling	↔	↔	R	No primary modulation	No established direct Ca²⁺ regulatory role.
8	Clinical Translation Constraint	—	—	—	Nutrient sufficiency only	Supplementation does not selectively target tumor metabolism; enzyme-level targeting (e.g., PANK inhibitors) is the investigational strategy.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr

Vitamin B5 (Pantothenic Acid; PA) = water-soluble precursor to Coenzyme A (CoA); common supplemental form: D-calcium pantothenate. Present in meats (esp. liver), seeds, fish, eggs, mushrooms; heat-labile to some extent; no long-term storage → requires regular intake.
Primary mechanisms (AD-relevant rank):
1) CoA synthesis → acetyl-CoA pool → acetylcholine (ACh) synthesis support.
2) Mitochondrial energy metabolism (TCA flux, β-oxidation) → neuronal bioenergetic stability.
3) Lipid metabolism (membrane phospholipids, myelin maintenance).
4) Indirect redox integration via mitochondrial throughput (secondary ROS modulation).
5) CoA turnover → cysteamine generation (putative BDNF modulation; limited human data).
PK / exposure: efficiently absorbed; plasma tightly regulated; excess rapidly excreted; oral dosing above AI does not proportionally elevate brain CoA once saturation is reached.
Clinical evidence status (AD): mechanistic plausibility strong; direct RCT evidence lacking; not an established disease-modifying therapy. AD relevance likely greater than cancer (where PA is largely metabolically permissive rather than therapeutic).

Vitamin B5 (Pantothenic Acid) — Alzheimer’s Disease–Relevant Axes

Rank	Pathway / Axis	Cells (neurons/glia)	TSF	Primary Effect	Notes / Interpretation
1	Acetyl-CoA → Acetylcholine synthesis	↑ (if deficient)	G	Supports ACh production	ACh reduced in AD; PA deficiency could worsen cholinergic deficit; supplementation restores only if suboptimal intake present.
2	Mitochondrial energy metabolism (TCA)	↑ (bioenergetic support)	R→G	ATP production stabilization	CoA central to acetyl-CoA flux; may support neurons under metabolic stress; not a direct ETC activator.
3	Lipid metabolism / membrane integrity	↑	G	Phospholipid turnover support	Neuronal membrane composition critical in AD; effect is permissive rather than corrective.
4	ROS tone (indirect)	↔ / ↓ (secondary)	R	Metabolic-redox coupling	No intrinsic antioxidant action; ROS shifts occur via improved mitochondrial efficiency (context-dependent).
5	BDNF (via cysteamine from CoA turnover)	↑ (theoretical / limited human data)	G	Neurotrophic modulation	Cysteamine crosses BBB and may increase BDNF; contribution from dietary PA not well quantified clinically.
6	NRF2 axis	↔	G	No direct activation	Not a canonical NRF2 modulator.
7	Ca²⁺ signaling	↔	R	No primary modulation	No direct Ca²⁺ regulatory role established.
8	Clinical Translation Constraint	—	—	Nutritional sufficiency ceiling	Adequate Intake ~5 mg/day; higher doses (10–15 mg/day typical supplementation; 300–900 mg/day under supervision) lack robust AD outcome trials.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr

Risk, Risk: Click to Expand ⟱

Source:

Type:

Risk: by definition reduces risk of disease or cancer.
Down Target direction of risk indicates lower cancer risk.
ChemoPreventive also mean lower cancer risk. But for Chemopreventive an up arrow indicates more preventive.

Cancer Risk Impact Score (CRIS)
CRIS scale:
–5 = very strong risk reduction
–4 = strong risk reduction
–3 = moderate risk reduction
–2 = modest risk reduction
–1 = weak / context-dependent
0 = neutral


CRIS  Exposure / Compound  Evidence  Cancers  Notes


-5  Exercise (overall)
VStrong Hum  BC, CRC, Endo, PCa, Liv
↓insulin/IGF-1, ↓inflammation, ↑immune surveillance, ↓hormones



-5  Aerobic + resistance  VStrong Hum  Broad inc + mort
Best overall exercise synergy



-4  Aerobic exercise (mod–vig)  VStrong Hum  BC, CRC, Endo
Dose–response; ↓visceral fat



-4  Resistance training (alone)  Strong Hum  BC, CRC
↑insulin sensitivity; ↑lean mass



-3  High-intensity interval training  Mod–Strong Hum  BC, CRC
↑AMPK; ↑mitochondrial function; adherence matters



-2  NEAT / low-intensity activity  Moderate Hum  CRC
↓sedentary harm



-5  Cruciferous vegetable pattern  Strong Hum  Lung, CRC, BC, PCa
↑NRF2, ↓CYP1; ITC synergy



-5  Sunlight exposure (physiologic)  Strong Hum  CRC, BC, PCa
↑circadian alignment, ↑immune effects beyond vitamin D



-4  Fasting (metabolic pattern)
Strong Mech + Hum  BC, CRC, PCa 
↓IGF-1, ↓mTOR, ↑autophagy



-4  Curcumin
Hum + Pre  GI, BC, PCa
↓NF-κB, ↓STAT3



-4  Sulforaphane
Hum + Pre  Lung, CRC, BC
↑NRF2, ↓HDAC



-4  PEITC
Hum + Pre  Lung, CRC, PCa
↓CYP1A2, ↑apoptosis



-4  EGCG (tea matrix)
Strong Hum  GI, PCa, BC
↓angiogenesis; tea matrix superior to extract



-4  Lycopene
Strong Hum  PCa
↓oxidative DNA damage



-4  Apigenin
Pre + Diet Hum  BC, PCa, CRC 
↓PI3K-AKT, ↑p53



-4  Luteolin
Pre + Diet Hum  Lung, CRC, BC 
↓STAT3, ↓EMT



-4  Kaempferol
Diet Hum  Ov, Panc, Lung
↓VEGF, ↑apoptosis



-4  Fisetin
Pre + Early Hum  CRC, PCa, Mel
↓mTOR; senolytic activity



-4  Ellagic acid → Urolithin A
Hum (microbiome)  CRC, PCa, BC
↑mitophagy, ↓ER/AR signaling



-3  Omega-3 (EPA/DHA)
Strong Hum  CRC, BC
↓inflammation, ↓COX-2



-3  Vitamin D3 (supp)
Obs + RCT  CRC, BC
U-shaped response; ↓proliferation



-3  Garlic (allicin)
Mod Hum  GI
↓inflammation, ↓H. pylori



-3  Mushroom beta-glucans
Hum adjunct  GI, BC
↑NK cells, ↑immune surveillance



-3  Melatonin
Hum + Mech  BC, PCa
↓estrogen signaling, ↑circadian regulation



-3  Coffee (whole)
Strong Hum  Liv, Endo
↓fibrosis, ↓inflammation



-2  Quercetin
Limited Hum  Lung, CRC
Senolytic; ↓PI3K signaling



-2  Resveratrol
Limited Hum  CRC, BC
↓NF-κB; low bioavailability



-2  I3C / DIM
Mod Hum  BC, Cerv
↑2-OH estrogen, ↓ER signaling



-2  Thymoquinone
Early Hum  BC, CRC
↑apoptosis, ↓NF-κB



-2  Beta-carotene (food)
Hum  Lung
Antioxidant only in whole-food context



-1  Vitamin K2 (MK-4/7)
Limited Hum  Liv, PCa
↓proliferation, ↑differentiation



-1  Boron
Obs  PCa, Lung
↓inflammation; hormone modulation



0  Vitamin C (oral)
Strong Hum  —
Neutral overall effect



0  Genistein (soy)
Strong Hum  BC, PCa
Timing-dependent effects



0  Selenium (diet)
Mixed Hum  PCa
Narrow therapeutic window



0  Capsaicin
Mixed  Gastric
Dose-dependent effects



+2  Vitamin E (alpha only)
Strong RCT  PCa
Increased risk signal



+2  Green tea extract (high-dose)
Case reports  Liv
Hepatotoxicity reported



+4  Beta-carotene (supplement)
Strong RCT  Lung (smokers)
Increased lung cancer risk in smokers



+5  Alcohol (ethanol)
Strong Hum  BC, Liv, Eso
Linear increase in cancer risk




Evidence
Hum        human data
VStrong    very strong
Strong     strong
Mod        moderate
Obs        observational
Pre        preclinical
RCT        randomized controlled trial
Mech       mechanistic
Adjunct    adjunct clinical use

Scientific Papers found: Click to Expand⟱

4323-

VitB5,

Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease

Study,

AD,

 nine AD cases and nine controls

*Risk↓, *Acetyl-CoA↑, *Ach↑, *neuroP↑,

4324-

VitB5,

Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia

Study,

AD,

Brain tissue was obtained from nine confirmed cases of PDD and nine controls with a post-mortem delay of 26 h or less.

Study,

Park,

*Risk↓, *other↝, *other↝, *Ach↑, *Aβ↑, *other?,

4326-

VitB5,

Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease

in-vivo,

HD,

analysed short-post-mortem-delay brain tissue from 30 cases of HD and 19 controls

*Risk↓, *neuroP↑, *other?, *Ach↑, *other↝, *eff↓, *other↝,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:

Total Targets: 0

Pathway results for Effect on Normal Cells:

Functional Outcomes ⓘ

neuroP↑, 2, Risk↓, 3,
Total Targets: 8

Scientific Paper Hit Count for: Risk, Risk

3 Vitamin B5,Pantothenic Acid

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:368  Target#:785  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

Vitamin B5,Pantothenic Acid / Risk Cancer Research Results

Vitamin B5 (Pantothenic Acid) — Cancer-Relevant Pathways

Vitamin B5 (Pantothenic Acid) — Alzheimer’s Disease–Relevant Axes

Pathway results for Effect on Cancer / Diseased Cells:

Pathway results for Effect on Normal Cells:

Core Metabolism/Glycolysis ⓘ

Transcription & Epigenetics ⓘ

Protein Aggregation ⓘ

Drug Metabolism & Resistance ⓘ

Functional Outcomes ⓘ

Home Page